Patents by Inventor David J. Kidney

David J. Kidney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained release oral dosage forms of an R-baclofen prodrug
    Patent number: 10071068
    Abstract: Sustained release oral dosage forms of an R-baclofen prodrug are disclosed.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: September 11, 2018
    Assignee: XENOPORT, INC.
    Inventors: David E. Edgren, David J. Kidney, Nikhil Pargaonkar, Derrick K. Kim, Gorm Yoder, Sarni Karaborni
  • Oral Dosage forms having a High Loading of a Gabapentin Prodrug
    Publication number: 20170035714
    Abstract: Sustained release oral dosage forms with a high loading of a gabapentin prodrug are disclosed.
    Type: Application
    Filed: October 14, 2016
    Publication date: February 9, 2017
    Inventors: Sami Karaborni, Laura E. Maurer, David J. Kidney
  • SUSTAINED RELEASE ORAL DOSAGE FORMS OF AN R-BACLOFEN PRODRUG
    Publication number: 20100255093
    Abstract: Sustained release oral dosage forms of an R-baclofen prodrug are disclosed.
    Type: Application
    Filed: March 3, 2010
    Publication date: October 7, 2010
    Applicant: XenoPort, Inc.
    Inventors: David E. Edgren, David J. Kidney, Nikhil Pargaonkar, Derrick K. Kim, Gorm Yoder, Sami Karaborni
  • ORAL DOSAGE FORMS HAVING A HIGH LOADING OF A GABAPENTIN PRODRUG
    Publication number: 20100226981
    Abstract: Sustained release oral dosage forms with a high loading of a gabapentin prodrug are disclosed.
    Type: Application
    Filed: March 5, 2010
    Publication date: September 9, 2010
    Applicant: XenoPort, Inc.
    Inventors: Sami Karaborni, Laura E. Maurer, David J. Kidney
  • SUSTAINED RELEASE ORAL DOSAGE FORMS OF A PRODRUG OF R-BACLOFEN AND METHODS OF TREATMENT
    Publication number: 20080206332
    Abstract: Sustained release oral dosage forms of R-baclofen and methods of treating diseases comprising orally administering such dosage forms are disclosed.
    Type: Application
    Filed: January 10, 2008
    Publication date: August 28, 2008
    Inventors: David J. Kidney, Kenneth C. Cundy, Srikonda Sastry, Manshiu Leung
  • Method for the management of incontinence
    Patent number: 6919092
    Abstract: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: July 19, 2005
    Assignee: ALZA Corporation
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Method for the management of incontinence
    Publication number: 20040043943
    Abstract: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
    Type: Application
    Filed: August 20, 2003
    Publication date: March 4, 2004
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Method for the management of incontinence
    Publication number: 20040037881
    Abstract: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
    Type: Application
    Filed: August 20, 2003
    Publication date: February 26, 2004
    Inventors: George V. Guittard, Francisco Ja, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Method for the management of incontinence
    Patent number: 6262115
    Abstract: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
    Type: Grant
    Filed: March 29, 1999
    Date of Patent: July 17, 2001
    Assignee: ALZA Coporation
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Method for the management of incontinence
    Publication number: 20010005728
    Abstract: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
    Type: Application
    Filed: February 16, 2001
    Publication date: June 28, 2001
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Oxybutynin therapy
    Patent number: 6124355
    Abstract: A composition comprising oxybutynin, a dosage form comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
    Type: Grant
    Filed: May 13, 1998
    Date of Patent: September 26, 2000
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Therapy for neurological diseases
    Patent number: 6036973
    Abstract: A dosage form is disclosed for administering 10 ng to 1200 mg tacrine to a patient in need of tacrine therapy.
    Type: Grant
    Filed: July 15, 1997
    Date of Patent: March 14, 2000
    Assignee: ALZA Corporation
    Inventors: George V. Guittard, Jerry D. Childers, Patrick S.-L. Wong, Fernando E. Gumucio, David J. Kidney
  • Dosage form and method for treating incontinence
    Patent number: 5912268
    Abstract: A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
    Type: Grant
    Filed: February 26, 1997
    Date of Patent: June 15, 1999
    Assignee: Alza Corporation
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Dosage form comprising oxybutynin
    Patent number: 5840754
    Abstract: A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
    Type: Grant
    Filed: September 5, 1996
    Date of Patent: November 24, 1998
    Assignee: ALZA Corporation
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando Gumucio
  • Tacrine therapy
    Patent number: 5698224
    Abstract: A dosage form is disclosed for administering 10 ng to 1200 mg tacrine to a patient in need of tacrine therapy.
    Type: Grant
    Filed: June 27, 1994
    Date of Patent: December 16, 1997
    Assignee: Alza Corporation
    Inventors: George V. Guittard, Jerry D. Childers, Patrick S. -L. Wong, Fernando E. Gumucio, David J. Kidney
  • Dosage form comprising oxybutynin
    Patent number: 5674895
    Abstract: A composition comprising oxybutynin and a device comprising oxybutynin are disclosed for oxybutynin therapy.
    Type: Grant
    Filed: May 22, 1995
    Date of Patent: October 7, 1997
    Assignee: Alza Corporation
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando Gumucio
  • Antiviral therapy
    Patent number: 5358721
    Abstract: A dosage form is disclosed for administering an antiviral drug to a patient in need of antiviral therapy.
    Type: Grant
    Filed: December 4, 1992
    Date of Patent: October 25, 1994
    Assignee: Alza Corporation
    Inventors: George V. Guittard, Patrick S. L. Wong, Anthony L. Kuczynski, David J. Kidney